Newest psychostimulant medication marketed by Merck, derived from dextroamphetamine but inteneded to be less harmful on the body. Planned for public release in 2012.
"My ADHD was gettin' off the hook, but then my shrink hooked me up with this new script for Methererem instead of Desoxyn, and now -- it's all good."
by rxscholar November 05, 2009